MeSH D006504 - hepatic veno-occlusive disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Gentium | Defibrotide | Defitelio | 2013-10-18 | |||
| Jazz Pharmaceuticals | Defibrotide | Defitelio | 2032-06-22 | 2016-03-30 | $209.998 M | Q4/23-Q3/24 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
33%1/3
Phase 3
60%3/5
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use